Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ENLV —
ENLIVEX THERAPEUTICS LTD
CUSIP: M4130Y106 · Held by 2 superinvestors · Combined value: $263,359
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $220,543 | 313,628 | ADD | +156,336 |
| 2 | Ken Griffin | 0.0% | $42,816 | 60,887 | REDUCE | -8,049 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | ADD | +156,336 | +99.4% |
| Ken Griffin | REDUCE | -8,049 | -11.7% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Jim Simons | REDUCE | -11,100 | -6.6% |
| Ken Griffin | REDUCE | -10,164 | -12.8% |
Who Owns ENLV? Superinvestor Holdings
ENLIVEX THERAPEUTICS LTD is held by 2 tracked superinvestors, with a combined position value of $263,359 . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 1 reduced or exited.